Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Contrast Agents for Magnetic Resonance Imaging (MRI) market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Contrast Agents for Magnetic Resonance Imaging (MRI) market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Contrast Agents for Magnetic Resonance Imaging (MRI), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Contrast Agents for Magnetic Resonance Imaging (MRI), also provides the sales of main regions and countries. Of the upcoming market potential for Contrast Agents for Magnetic Resonance Imaging (MRI), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Contrast Agents for Magnetic Resonance Imaging (MRI) sales, projected growth trends, production technology, application and end-user industry.
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Company
Daiichi Sankyo (Japan)
Bayer HealthCare (Germany)
Unijules Life Sciences (India)
Taejoon Pharm (South Korea)
Spago Nanomedicine (Sweden)
Magnus Health (India)
Lantheus (US)
Jodas (India)
J.B. Chemicals and Pharmaceuticals (India)
Guerbet (France)
GE Healthcare (US)
Bracco Imaging (Italy)
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type
Microbubble Contrast Media
Gadolinium-based Contrast Media
Iodinated Contrast Media
Barium-based Contrast Media
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application
Radiology
Interventional Radiology
Interventional Cardiology
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Contrast Agents for Magnetic Resonance Imaging (MRI) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Contrast Agents for Magnetic Resonance Imaging (MRI) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Contrast Agents for Magnetic Resonance Imaging (MRI) significant trends, drivers, influence factors in global and regions.
6. To analyze Contrast Agents for Magnetic Resonance Imaging (MRI) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Contrast Agents for Magnetic Resonance Imaging (MRI) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contrast Agents for Magnetic Resonance Imaging (MRI) industry.
Chapter 3: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Contrast Agents for Magnetic Resonance Imaging (MRI) market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Contrast Agents for Magnetic Resonance Imaging (MRI) market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Contrast Agents for Magnetic Resonance Imaging (MRI), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Contrast Agents for Magnetic Resonance Imaging (MRI), also provides the sales of main regions and countries. Of the upcoming market potential for Contrast Agents for Magnetic Resonance Imaging (MRI), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Contrast Agents for Magnetic Resonance Imaging (MRI) sales, projected growth trends, production technology, application and end-user industry.
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Company
Daiichi Sankyo (Japan)
Bayer HealthCare (Germany)
Unijules Life Sciences (India)
Taejoon Pharm (South Korea)
Spago Nanomedicine (Sweden)
Magnus Health (India)
Lantheus (US)
Jodas (India)
J.B. Chemicals and Pharmaceuticals (India)
Guerbet (France)
GE Healthcare (US)
Bracco Imaging (Italy)
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type
Microbubble Contrast Media
Gadolinium-based Contrast Media
Iodinated Contrast Media
Barium-based Contrast Media
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application
Radiology
Interventional Radiology
Interventional Cardiology
Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Contrast Agents for Magnetic Resonance Imaging (MRI) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Contrast Agents for Magnetic Resonance Imaging (MRI) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Contrast Agents for Magnetic Resonance Imaging (MRI) significant trends, drivers, influence factors in global and regions.
6. To analyze Contrast Agents for Magnetic Resonance Imaging (MRI) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Contrast Agents for Magnetic Resonance Imaging (MRI) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contrast Agents for Magnetic Resonance Imaging (MRI) industry.
Chapter 3: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
197 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 1.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2020-2031)
- 1.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Dynamics
- 2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
- 2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers
- 2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges
- 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints
- 3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Company
- 3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Revenue Ranking in 2024
- 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (2020-2025)
- 3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Company (2020-2025)
- 3.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Company (2020-2025)
- 3.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Ranking (2023-2025)
- 3.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Manufacturing Base and Headquarters
- 3.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Product Type and Application
- 3.8 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Contrast Agents for Magnetic Resonance Imaging (MRI) Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Type
- 4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Type Introduction
- 4.1.1 Microbubble Contrast Media
- 4.1.2 Gadolinium-based Contrast Media
- 4.1.3 Iodinated Contrast Media
- 4.1.4 Barium-based Contrast Media
- 4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type
- 4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2020-2031)
- 4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Type (2020-2031)
- 4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type
- 4.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2020-2031)
- 4.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type (2020-2031)
- 5 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Application
- 5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Application Introduction
- 5.1.1 Radiology
- 5.1.2 Interventional Radiology
- 5.1.3 Interventional Cardiology
- 5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application
- 5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2020-2031)
- 5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Application (2020-2031)
- 5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application
- 5.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2020-2031)
- 5.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application (2020-2031)
- 6 Contrast Agents for Magnetic Resonance Imaging (MRI) Regional Sales and Value Analysis
- 6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2020-2031)
- 6.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2020-2025
- 6.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2026-2031)
- 6.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2020-2031)
- 6.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region: 2020-2025
- 6.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2026-2031)
- 6.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 6.6.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 6.7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 6.9.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2024 VS 2031
- 7 Contrast Agents for Magnetic Resonance Imaging (MRI) Country-level Sales and Value Analysis
- 7.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2031)
- 7.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025)
- 7.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2026-2031)
- 7.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2020-2031)
- 7.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2020-2025)
- 7.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.9.2 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.16.2 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.19.2 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Daiichi Sankyo (Japan)
- 8.1.1 Daiichi Sankyo (Japan) Comapny Information
- 8.1.2 Daiichi Sankyo (Japan) Business Overview
- 8.1.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.1.5 Daiichi Sankyo (Japan) Recent Developments
- 8.2 Bayer HealthCare (Germany)
- 8.2.1 Bayer HealthCare (Germany) Comapny Information
- 8.2.2 Bayer HealthCare (Germany) Business Overview
- 8.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.2.5 Bayer HealthCare (Germany) Recent Developments
- 8.3 Unijules Life Sciences (India)
- 8.3.1 Unijules Life Sciences (India) Comapny Information
- 8.3.2 Unijules Life Sciences (India) Business Overview
- 8.3.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.3.5 Unijules Life Sciences (India) Recent Developments
- 8.4 Taejoon Pharm (South Korea)
- 8.4.1 Taejoon Pharm (South Korea) Comapny Information
- 8.4.2 Taejoon Pharm (South Korea) Business Overview
- 8.4.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.4.5 Taejoon Pharm (South Korea) Recent Developments
- 8.5 Spago Nanomedicine (Sweden)
- 8.5.1 Spago Nanomedicine (Sweden) Comapny Information
- 8.5.2 Spago Nanomedicine (Sweden) Business Overview
- 8.5.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
- 8.6 Magnus Health (India)
- 8.6.1 Magnus Health (India) Comapny Information
- 8.6.2 Magnus Health (India) Business Overview
- 8.6.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.6.5 Magnus Health (India) Recent Developments
- 8.7 Lantheus (US)
- 8.7.1 Lantheus (US) Comapny Information
- 8.7.2 Lantheus (US) Business Overview
- 8.7.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.7.5 Lantheus (US) Recent Developments
- 8.8 Jodas (India)
- 8.8.1 Jodas (India) Comapny Information
- 8.8.2 Jodas (India) Business Overview
- 8.8.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.8.5 Jodas (India) Recent Developments
- 8.9 J.B. Chemicals and Pharmaceuticals (India)
- 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Comapny Information
- 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
- 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
- 8.10 Guerbet (France)
- 8.10.1 Guerbet (France) Comapny Information
- 8.10.2 Guerbet (France) Business Overview
- 8.10.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.10.5 Guerbet (France) Recent Developments
- 8.11 GE Healthcare (US)
- 8.11.1 GE Healthcare (US) Comapny Information
- 8.11.2 GE Healthcare (US) Business Overview
- 8.11.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.11.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.11.5 GE Healthcare (US) Recent Developments
- 8.12 Bracco Imaging (Italy)
- 8.12.1 Bracco Imaging (Italy) Comapny Information
- 8.12.2 Bracco Imaging (Italy) Business Overview
- 8.12.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
- 8.12.5 Bracco Imaging (Italy) Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Analysis
- 9.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Mode & Process
- 9.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
- 9.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



